Form: EFFECT

Notice of Effectiveness

April 8, 2025

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: April 8, 2025
Accession Number: 0001628280-25-016815
Submission Type: POS AM
CIK: 0001815776
Company Name: LENZ Therapeutics, Inc.
File Number: 333-282036